Stanley Center for the Innovative Treatment of Bipolar Disorder

FIFTH INTERNATIONAL CONFERENCE 
ON BIPOLAR DISORDER



Introduction

Proceedings

Bipolar Conferences Home

Thursday, June 12, 2003
"Concurrent Rapid Communications Sessions"

Session A - Chair: Samuel Gershon, M.D.
Bibliography

Familial Relationship Between Bipolar Disorder Alcohol and Heroin Dependence

Video  |  Audio (Length:  22 min.)

M. Preisig1, F. Ferrero2
1Psychiatric University Department, Lausanne, Switzerland, 2University Hospital, Department of Psychiatry, Geneva, Switzerland

Background: Clinical and epidemiological studies have consistently revealed an association between bipolar disorders and both alcohol and heroin dependence. However, the evidence regarding the nature of these associations is unclear. 
Methods:
The familial patterns of alcohol and affective disorders were examined using data from a study of 118 treated bipolar-I, 32 alcohol and 33 heroin dependent probands as well as 88 normal controls recruited in orthopedic departments. These probands had 1073 first degree relatives. Probands and all available first-degree relatives who agreed to participate were assessed using the Diagnostic Interview for Genetic Studies (DIGS).
Results:
The major findings are that 1) bipolar-I disorder was associated with alcohol (OR = 2.1) and heroin dependence (OR = 6.0) in the relatives; 2) there was a strong degree of familial aggregation of bipolar-I disorder (OR = 7.1), alcohol (OR = 2.3) and heroin dependence (OR = 4.0); 3) there was evidence of cross-aggregation between bipolar-I disorder and alcohol dependence (i.e., increased risk of alcohol dependence among relatives of probands with bipolar disorder without alcohol dependence, but not the converse); 4) there was no evidence of cross-aggregation between bipolar-I disorder and heroin dependence. 
Conclusion:
Our data suggest different mechanisms underlying the associations between bipolar-I disorder and alcohol dependence and bipolar disorder and heroin dependence. The independent familial aggregation of bipolar disorder and heroin dependence and the finding that the onset of bipolar disorder tended to precede that of heroin dependence are compatible with a self-medication hypothesis as the explanation for the frequent co-occurrence of these disorders. In contrast, the finding of cross- aggregation between bipolar-I disorder and alcohol dependence could be either an artifact and result from undetected bipolar disorder in alcoholic probands or indicate shared etiological factors between bipolar-I disorder and alcohol dependence.


An fMRI Study of Altered Load-Response Characteristics During Verbal Working Memory Task Performance in Euthymic Bipolar I Disorder

Video  |  Audio (Length:  24 min.)

P.J. Monks1, J.M. Thompson2, N. Giles1, J. Suckling3, E.T. Bullmore3, M.J. Brammer1, S.C.R. Williams1, A. Simmons1, R.M. Murray1, I.N. Ferrier2, A.H. Young2, V.A. Curtis1
1Division of Psychological Medicine, Institute of Psychiatry, London, 2Stanley Bipolar Research Foundation, Psychiatry Department, Newcastle University, 3Department of Psychiatry, University of Cambridge School of Clinical Medicine, Addenbrookes Hospital, Cambridge, UK

Introduction: We used fMRI to investigate load-dependent neural network engagement during executive and mnemonic function in Bipolar Disorder.
Methods: 12 euthymic dextral male Bipolar I subjects receiving Lithium monotherapy were matched with 12 controls. We utilized a “Sternberg” task with a parametric design incorporating variable working memory load, and a “two-back” task contrasting a single memory load with a baseline recognition condition. Data were fitted to haemodynamic response models convolved with experimental design: Two-back, active-versus-baseline contrast and, Sternberg, overall activation versus baseline. Group difference maps were produced for each of these pairs of group maps by ANOVA. 4 regions of interest were identified in the Sternberg group-difference map and load-response (LR) curves were plotted for activation data at each.
Results: No significant group-differences in accuracy or response time were observed. In the Two-back experiment, the Bipolar subjects were hypofrontal compared with Controls. During the Sternberg task both groups engaged similar fronto-temporal networks. There was greater activation (p=0.05): for Bipolars at right cerebellar, caudate, occipital, superior frontal and left insular, hippocampal and paracentral loci; for Controls at right cerebellar, temporal, lingual, medial frontal, parietal, precentral and left putamen, anterior cingulate, lateral frontal and bilateral hippocampal loci. Both groups showed negative LR relationships at right medial frontal gyrus and left temporo-occipital junction. Within right caudate nucleus and right hippocampus, the groups showed different LR relationships. In Bipolars, it was positive (increasing recruitment with increasing load) whilst in controls it was negative.
Discussion: We have demonstrated differing neural network activation in Bipolar and Control subjects performing verbal working memory tasks. The Bipolar group shows evidence of both hypofrontality and increasing recruitment with load of right caudate and hippocampus. This may represent enhanced recruitment of normally functioning regions to compensate for abnormalities elsewhere or abnormal function of these specific regions.
Keywords:  functional MRI, working memory, frontal lobe function.


Changes in Brain Activation in Bipolar Patients with Increasing Number of Depressive Episodes

Video  |  Audio (Length:  26 min.)

C.M. Adler, S.M. Strakowski
University of Cincinnati College of Medicine, Cincinnati, OH, USA

Background: We have previously found that bipolar patients demonstrate significant deficits in working memory, an aspect of short-term memory essential to function, in comparison with healthy volunteers. These deficits are accompanied by patterns of increased neuronal activation within the working memory “network.” Functional deficits may reflect the neuropathologic consequences of repeated episodes of affective symptomatology. We followed up our previous findings by utilizing functional magnetic resonance imaging (fMRI) to examine changes in neuronal activation with increasing number of affective episodes in bipolar patients.
Methods: Bipolar patients performed “zero-back” and “two-back” tasks in a boxcar design during fMRI scanning; the “zero-back” served as contrast condition for the “two-back” task. All scans were normalized to Talairach space. Voxel-by-voxel Spearman correlation coefficients were calculated between changes in blood flow and history of affective symptomatology. Cluster analysis technique was employed to control for Type I error. In a secondary analysis, individual voxel t-statistics were averaged across regions-of-interest (ROIs) within the medial temporal cortex, and mean Spearman correlation coefficients determined. Cognitive data were analyzed by discriminability and correlation coefficients determined between performance and affective history.
Results: Working memory performance inversely correlated to number of depressive episodes. On voxel-by-voxel analysis, patients demonstrated increased activation of anterior cingulate with increased number of affective episodes. In addition, ROI analysis demonstrated decreased left hippocampal activation with increased occurrence of depression.
Conclusions: These data are consistent with suggestions that depressive episodes in bipolar patients are associated with decrements in cognition. Activation changes may reflect underlying neuropathology leading to cognitive decline. Hippocampus has been demonstrated to be acutely sensitive to a variety of stimuli, including increased stress-related hormones. The anterior cingulate has been observed to act as a mediating element in cognitive networks and increased activation may represent efforts to compensate for decrements in performance elsewhere in the working memory network.
Keywords:  bipolar disorder, depression, fMRI.


Session B - Chair: Lauren Marangell, M.D.
Bibliography

Effectiveness of a Population-Based Care Management Program for People with Bipolar Disorder

Video  |  Audio (Length:  15 min.)

G.E. Simon, E.J. Ludman, J. Unutzer, M.S. Bauer, C. Rutter, B. Operskalski
Center for Health Studies, Group Health Cooperative, Seattle, WA, USA

Background: Care of bipolar disorder in everyday practice often falls short of that proven efficacious in clinical trials.
Objective: Evaluate the effectiveness of a multi-component care management program for bipolar disorder based on the chronic care model of by Wagner and Von Korff.
Design: Randomized control trial with concealed assignment and blinded outcome assessment.
Setting: 4 Behavioral health clinics of group-model managed care organization during 1999 to 2001.
Patients: A population-based sample of 441 patients treated for bipolar disorder during the prior year. Willingness to accept treatment was not required.
Intervention: Participants were randomly assigned to continued usual care or a systematic care management program including: initial assessment and care planning, monthly telephone monitoring including structured assessment of symptoms and medication use, feedback to and coordination with the mental health treatment team, and a structured group psychoeducational program (Bauer and McBride’s Life Goals Program) – all provided by a dedicated nurse care manager.
Main Outcome Measures: Weekly ratings of severity of depression and mania symptoms using the Longitudinal Interval Follow-Up Evaluation.
Results: Of those randomized to the intervention, 95% participated in telephone monitoring and 65% in the psychoeducational group. Based on intent to treat, intervention patients had significantly lower mean mania ratings averaged across the 12-month follow-up period (Z=2.44, p=.015) and approximately one-third less time in full hypomanic or manic episode (2.59 weeks vs. 1.69 weeks, p=). Mean depression ratings over 12 months did not differ significantly between groups, but intervention participants showed a greater decline in depression over time (Z statistic for group-by-time interaction = 1.98, p=.048).
Conclusions: A systematic care program proved feasible and well-accepted in a population-based sample. Compared to usual care, the program significantly reduced risk of mania over 12 months. Preliminary results suggest a growing effect on depression over time, but longer follow-up will be needed.
Keywords:  randomized trial, group psychotherapy, care management.


Efficacy and Acceptability of Valproate in Acute Mania

Video  |  Audio (Length:  17 min.)

J.R. Geddes, K. Macritchie
University of Oxford, Warneford Hospital, Oxford, UK

Objectives: To determine the efficacy and acceptability of valproate in the treatment of acute episodes of bipolar disorder.
Design: Systematic review and meta-analysis of randomized controlled trials.
Search strategy: The search included the Cochrane Collaboration Depression, Anxiety and Neurosis Controlled Trials Registrar (CCDANCTR), the Cochrane Controlled Clinical Trials Register (CCTR), reference lists of relevant papers and books, and contact with authors of trials, experts and pharmaceutical companies.
Results: Ten randomized controlled trials were found comparing valproate with other interventions in mania. None was found examining its use in depression or mixed affective episodes. Valproate was more efficacious than placebo (RRR 38%; RR 0.62; 95% C.I. 0.51 to 0.77) in the treatment of mania. There was no significant difference between valproate and lithium (RRI 5%; RR 1.05; 95% C.I. 0.74-1.50) or between valproate and carbamazepine (RRR 34%; RR 0.66; 95% C.I. 0.38 to 1.16). Valproate was less effective than olanzapine (failure to achieve clinical response; RRI 25%; RR 1.25, 95% C.I. 1.01 to 1.54; average of 2.8 point less change on the Mania Rating Scale (95% CI 0.83 to 4.79). There were no significant differences in acceptability as measured by total number of subjects withdrawing from the study. There were significant differences in the side effect profiles of valproate and olanzapine, with more sedation and weight gain on olanzapine.
Conclusions: There is consistent, if limited, evidence to suggest that valproate is an efficacious treatment for acute mania. Valproate appears to be less effective than olanzapine but may cause less sedation and weight gain. More well designed, randomized controlled trials investigating the relative efficacy and acceptability of valproate in the treatment of the full range of acute affective episodes occurring in bipolar disorder are required.
Keywords:  valproate, bipolar disorder, mania.


Divalproex Sodium verses Lithium Carbonate in the Treatment of Children and Adolescents with Bipolar Disorder

Video  |  Audio (Length:  23 min.)

R.L. Findling, J.R. Calabrese, E.A. Youngstrom
University Hospitals of Cleveland/Case Western Reserve University, Cleveland, OH, USA

Introduction: The primary objective of this study was to compare lithium (Li+) and divalproex (DVPX) monotherapy as a maintenance treatment for clinically stable children and adolescents.
Methods: Medically healthy youths ages 5-17 years with a lifetime history of BP-I or BP- II were eligible to participate. Those that achieved syndromal remission for four consecutive weeks with combination Li+ and DVPX treatment were then eligible for study randomization. Subjects were randomized to receive up to 76 weeks of Li+ or DVPX monotherapy treatment in a double-blind fashion. Serum blood levels were maintained at therapeutic levels by an unblinded medical monitor. Survival analyses examined differences in time to discontinuation due to a mood event and discontinuation for any reason. Cox regression examined predictors of length of survival time in the study.
Results: Sixty youths (39 males, 21 females) with an average age of 10.7 (3.6) years were randomized to receive either Li+ (n=30) or DVPX (n=30). The treatment groups did not differ in terms of survival time until a mood event: Li+ median 112 days, S.E.+ 67.0 days versus DVPX median 84 days, S.E.+ 58.6 days; Log Rank (1 df) = 0.33, p = 0.563. Also, median survival times until discontinuation for any reason did not differ between Li+ (83 days, S.E.+ 41.0 days) and DVPX (56 days, S.E.+ 13.9 days); Log Rank (1 df) = 0.28, p = 0.597. Post hoc analyses found that youths with the rapid cycling form of bipolarity obtained more sustained treatment response with lithium.
Conclusions: Overall, Li+ and DVPX appear to have similar efficacy as monotherapy for maintenance treatment of children and adolescents with bipolar disorder. For young patients with rapid cycling, it appears lithium may be a superior maintenance therapy.
Keywords:  children, adolescents, treatment.


A Case Control Study in the Use of Telemedicine for Treatment Adherence and Improved Outcomes in Remote and Rural Patients with Bipolar Disorder

Video   Audio (Length:  31 min.)

R. Dsouza, D. Rich
Mental Health Research Institute, Box Hill Hospital, Melbourne, Australia

Objectives: To study retrospectively the outcomes of remote and rural patients with a bipolar disorder admitted to a tertiary psychiatric center. Patients and significant other received continuing discharge planning and CERRPM Model of Psycho-education (Illness Management Skills Enhancement Programme) through telemedicine were compared with the outcomes of a matched sample of patients from the unit, who were discharged using conventional discharge summaries to their primary care physician.
Method: 20 rural inpatients who had received Telemedicine for discharge plans, continuing care and follow up over a 12 month period (TMG) and 21 rural inpatients who had discharge summaries sent to their primary care physician with ongoing care from the primary care physician (CG) were selected after matching for age, sex and axis I diagnosis.  A questionnaire, which studied 1. Satisfaction with the medication prescribed 2. Adverse affects of medication 3. Compliance with treatment. 4. Satisfaction with their case managers 5. Satisfaction with psychiatric management. 6. Rehospitalization data case records were studied. Case managers were consulted.
Results: Response rate higher with TM group. (TMG 90% CG 70%) Significantly higher scores with the TMG in areas of satisfaction with medication and case managers. TMG had higher compliance with treatment and significantly lower side effects with medication prescribed. TMG had significantly lower rehospitalization than CG. Thus better outcomes and quality of life. Both groups were satisfied with their diagnosis and treatment at the tertiary center.
Conclusion: This model of use of Telemedicine for remote and rural patients with bipolar disorder can enhance treatment adherence and improve outcomes. Telemedicine established and maintained therapeutic alliance with the rural case managers. Over all there were improved longitudinal outcomes, thus resulting in improved quality of life and a significant positive impact on the health economics for the service and the bipolar patient.
Keywords:  telemedicine, bipolar disorder, treatment adherence.

Top of Page


Introduction | Proceedings | Bipolar Conferences Home

© The Department of Psychiatry, University of Pittsburgh School of Medicine